Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis by Füsun Şahin et al.
Şahin et al. Multidisciplinary Respiratory Medicine 2012, 7:38
http://www.mrmjournal.com/content/7/1/38ORIGINAL RESEARCH ARTICLE Open AccessProminent features of platelet count, plateletcrit,
mean platelet volume and platelet distribution
width in pulmonary tuberculosis
Füsun Şahin*, Esra Yazar and Pınar YıldızAbstract
Background: We aimed to investigate the relation of platelet count (PLT) and plateletcrit (PCT), mean platelet
volume (MPV) and platelet distribution width (PDW) with other acute phase reactants and radiological extent in
pulmonary tuberculosis (PTB).
Methods: One hundred patients with PTB (Group 1), 50 patients with community-acquired pneumonia (Group 2)
and 28 healthy control individuals (Group 3) were included in this analytic study.
Results: WBC (White Blood Cell), ESR (Eritrocyte Sedimentation Rate), CRP (C-Reactive Protein), PLT and PCT values
were both in Group 1 and Group 2 than in Group 3. PDW values were significantly higher in Group 1 than Group 3.
WBC, ESR and CRP values were lower, while PLT and PCT values were higher in the Group 1 compared to Group 2
(p < 0.001). PLT was positively correlated with CRP and ESR values in the tuberculosis group (p < 0.001), while it was
not correlated with CRP and ESR in the pneumonia group (p > 0.05). ESR, CRP, PLT and PCT values were found
higher in radiological advanced stage (Stage 3) patients with PTB, while hemoglobin (Hb) was found lower
(p < 0.05). Higher WBC, ESR, CRP and PCT values as well as radiological advanced stage were more common in PTB
patients with thrombocytosis compared to the patients with normal platelet count, whereas Hb was found lower in
these patients.
Conclusions: This study indicates that reactive thrombocytosis and higher PCT and PDW develop frequently in PTB
and there is a relation between thrombocytosis and acute phase reactants, that is the inflammatory response. In
addition, tuberculosis with radiological advanced stage is seen more frequently in the patients with thrombocytosis
and higher PCT, drawing attention to the possible role of platelets in the cell-based immune process of
tuberculosis.
Keywords: Mean platelet volume, Platelet, Plateletcrit, Platelet distribution width, Pneumonia, Pulmonary
tuberculosis, ThrombocytosisBackground
Besides hemostasis, platelets are accepted to play a role
also in inflammatory response [1-3]. It has been demon-
strated that changes in platelet count, especially during
the course of bacterial infections might be associated
with the severity and mortality of the infection. More-
over, patients with thrombocytosis (among the patients
hospitalized due to community-acquired pneumonia)* Correspondence: fusunsahin19700@hotmail.com
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reproduction in any medium, provided the orhave been reported to carry a high risk of mortality [3].
Existence of thrombocytosis has been shown in many
studies investigating the hematological changes in tuber-
culosis [2,4-6]. Furthermore, the increase in the platelet
count has been reported to be correlated with the sever-
ity of tuberculosis and acute phase reactants [1,2]. Thus,
in addition to clinical and radiological findings, it has
been indicated that platelet count and indices might be
used together with the other acute phase reactants in
order to define activation of tuberculosis [1,2]. Objective
of this study was to investigate the relation between the
existence of thrombocytosis, platelet and indices withd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stage of the disease in patients with PTB. In addition,
patients who developed acute bacterial pneumonia due
to non-tuberculous factors were also included in the
study in order to discuss the possible role of platelets in
immunopathogenesis of PTB.
Methods
This is an analytic study. The study was performed in
accordance with the principles of the Declaration of
Helsinki and approved by the ethics committee of the
hospital (Yedikule Chest Diseases and Thoracic Surgery
Training and Research Hospital).
One hundred consecutive patients with active lung tu-
berculosis referred to Chest Diseases and Thoracic Sur-
gery Training and Research Hospital between 2008 and
2010 (Group 1), 50 age and gender matched patients
with community-acquired pneumonia (CAP, Group 2)
and 28 healthy controls (Group 3) were included in the
study. Sputum AFB (with Ziehl-Neelsen stain) and at
least one culture (Löwenstein-Jensen media and BAC-
TEC TB 460 system) were found positive in all patients
in the group 1 and accepted as active lung tuberculosis.
Patients with PTB were classified as stage 1 (minimal/
mild), stage 2 (moderate) and stage 3 (advanced) accord-
ing to the extent of the disease on the chest radiographs
[7,8]. Lesions were considered to be ‘minimal’ if they
were of slight to moderate density without cavitation
and involved a part of one or both lungs, the total extent
being less than the volume of lung on one side which
was present above the second chondrosternal junction.
Moderate lesions were present in one or both lungs, but
the total extent did not exceed the following limits: dis-
seminated lesions of slight to moderate density which
extended throughout the total volume of one lung, or
the equivalent in both lungs; dense and confluent lesions
which were limited in extent to one third of the volume
of one lung; total diameter of cavitation, when present,
was less than 4 cm. When the lesions were more exten-
sive than these were recorded as ‘advanced’. PTB
patients were divided into two groups based on
thrombocyte counts and a trombocyte count higher than
400x103/l was considered as thrombocytosis: 56 PTB
patients with normal thrombocyte count, 44 PTB
patients with reactive thrombocytosis. Reactive Throm-
bocytosis: it is meant that PLT count is higher than
400.000/μL. CAP (Group 2) was defined as the presence
of a new pulmonary infiltrate on chest radiography that
was cleared by antibiotic therapy at the time of diagnosis
associated with at least one of the following: cough, fever
and leukocytosis. Subjects were excluded from the study
if there was a history of severe cardiovascular disease,
significant liver or autoimmune disorders, neoplasm and
immunosuppressive conditions.Normal healthy individuals presenting for routine
examination and with no complaint or known disease
with a normal chest radiography were included in the
control group. Full blood counts were carried out using
“ABX Pentra 120 (Impedance&Optical, Minnesota,
USA)”, serum levels of CRP (C-Reactive Protein) with
“Olympus AU2700 Plus Beckman Coulter (Tokyo,
Japan)” and ESR (Eritrocyte Sedimentation Rate) with
“Eriline AR Linear (Barcelona, Spain)” devices in each of
the three groups.
Statistical analysis
All the statistical analyses were performed using SPSS
11,5 package software (SPSS Inc., Chicago, IL, USA).
“OnewayAnova Analysis of Variance” test was used in
inter-group comparisons and “Pearson and Spearman
Correlation Tests” in assessment of the correlation be-
tween the numerical and categorical parameters. Com-
parison of the laboratory values in PTB group according
to radiological stage and existence of thrombocytosis
was performed using “Mann Whitney-U Test.” p <0.05
values were considered statistically significant. The best
cut-off values of PLT and PCT in differentiation of tu-
berculosis and pneumonia was calculated with “ROC
Curve Analysis”.
Results
WBC, ESR, CRP, PLT and PCT values were significantly
higher both in Group 1 and Group 2 than in Group 3.
On comparison of Group 1 and Group 3; Hb values
were lower, while PDW values were higher. On compari-
son of Group 1 and Group 2; WBC, ESR and CRP values
were lower, while PLT and PCT values were higher in
the Group 1 compared to Group 2 (p < 0.001). PLT was
correlated with CRP and ESR values in the tuberculosis
group (r = 0.57, r = 0.56, p < 0.001; respectively), while it
was not correlated with CRP and ESR in the pneumonia
group (r = 0.20, r = 0.26, p > 0.05, respectively). Charac-
teristics of the groups and laboratory outcomes are given
in Table 1.
Patients with pulmonary tuberculosis were classified as
stage 1 (n = 8), stage 2 (n = 72) and stage 3 (n = 20)
according to the radiological extent. Stage 1 and 2
patients (n = 80) were compared with stage 3 (n = 20)
patients. ESR, CRP, PLT and PCT values were higher in
the patients with advanced stage (stage 3), while Hb was
found lower in these patients. The increase in the plate-
let counts and PCT in advanced stage PTB was corre-
lated both with the increase in CRP (r = 0.69, p < 0.01)
and ESR (r = 0.56, p < 0.05). In addition, the rate of male
gender was found higher in advanced stage tuberculosis.
General characteristics and laboratory outcomes of the
patients with pulmonary tuberculosis according to the
radiological stage are given in Table 2.
Table 1 Characteristics and laboratory outcomes of the groups
Group 1 Group 2 Group 3 Group 1-2 Group 1-3 Group 2-3
(n = 100) (n = 50) (n = 28) p value p value p value
Age 38.9 ± 15.3 37.5 ± 15.1 39.4 ± 13.0 0.81 0.72 0.36
Sex, F/M 19/81 10/40 10/18 0.08 0.06 0.052
Hb, g/dL 12.3 ± 1.4 12.8 ± 1.5 13.4 ± 1.0 0.12 0.002* 0.19
WBC, μL 8473 ± 2222 18194 ± 4046 7157 ± 1528 <0.0001* 0.002* <0.0001*
PLT,x103/μL 384.5 ± 122 304.4 ± 88.3 253.78 ±55 <0.0001* <0.0001* 0.008*
PDW, % 14.7 ± 2.0 14.5 ± 2.3 13.5 ± 1.8 0.90 0.004* 0.14
MPV, fL 8.54 ±1.39 8.74 ± 0.71 8.65 ± 0.52 0.58 0.89 0.90
PCT, % 0.33 ±0.09 0.27 ± 0.05 0.21 ± 0.04 <0.0001* <0.0001* 0.007*
ESR, mm/h 69.2 ± 25.5 85.5 ± 21.6 15.9 ± 3.5 <0.0001* <0.0001* <0.0001*
CRP, mg./L 6.3 ± 4.7 15.5 ± 7.2 0.4 ± 0.2 <0.0001* <0.0001* <0.0001*
*Significant value (p < 0.05).
Group1, Pulmonary Tuberculosis; Group2, Pneumonia; Group 3, Healthy control; F/M,Female/Male; Hb, Hemoglobin; WBC, White blood cell; PLT, Platelet; PDW,
Platelet distribution width; MPV, Mean platelet volüme; PCT,: Plateletcrit; ESR,Eritrocyte sedimentation rate; CRP, C-reactive protein.
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groups as the patients with a normal platelet count (n =
56) and those with thrombocytosis (n = 44). WBC, ESR,
CRP and PCT values were higher in the patients with
thrombocytosis compared to those with a normal plate-
let count, while Hb was found lower in these patients. In
addition, radiological advanced stage disease was more
common in the patients with thrombocytosis. General
characteristics and laboratory outcomes of the patients
with pulmonary tuberculosis according to the platelet
count are given in Table 3.
ROC curve analysis was performed for the PLT and
PCT values among TB patients vs controls (pneumonia
and pneumonia + healthy control). The best PLT cut-offTable 2 General characteristics and laboratory outcomes
of the patients with pulmonary tuberculosis according to
the radiological stage
Stage 1,2 PTB Stage 3 PTB p value
(n = 80) (n = 20)
Age 39.2 ± 15.9 37.8 ± 12.9 0.47
Sex, F/M 18/62 1/19 0.02*
Hb, g/dL 12.5 ± 1.5 11.9 ± 1.2 0.004*
WBC, μL 8369 ± 2398 8890 ±1266 0.85
PLT, x103/μL 357 ± 108 491 ± 120 <0.0001*
PDW, % 14.8 ± 2.0 14.0 ± 2.2 0.23
MPV, fL 8.6 ± 1.5 8.3 ± 1.0 0.52
PCT, % 0.30 ± 0.07 0.4 ± 0.1 <0.0001*
ESR, mm/h 66 ± 26 83 ± 17 0.003*
CRP, mg/L 5.7 ± 4.9 9.1 ± 3.0 <0.0001*
*Significant value (p < 0.05).
PTB, Pulmonary tuberculosis; F/M, Female/Male; Hb, Hemoglobin; WBC, White
blood cell; PLT, Platelet; PDW, Platelet distribution width; MPV, Mean platelet
volüme; PCT, Plateletcrit; ESR, Eritrocyte sedimentation rate; CRP, C-reactive
protein.value in differential diagnosis of tuberculosis and pneu-
monia was defined as 335000/μL. For this cut off value,
sensitivity was found as 64%, specificity as 60%, positive
predictive value as 76.2% and negative predictive value
as 45.5% (Figure 1).
The best PLT cut-off value in differential diagnosis of
tuberculosis and pneumonia + healthy control was
defined as 320000/μL. For this cut off value, sensitivity
was found as 70% specificity as 69.2%, positive predictive
value as 74.5% and negative predictive value as 64.3%
(Figure 2).
The best PCT cut-off value in differential diagnosis of
tuberculosis and pneumonia was defined as 0.275%. For
this cut off value, sensitivity was found as 64%,Table 3 General characteristics and laboratory outcomes







(n = 44) (n = 56)
Age 40.5 ± 15.4 37.7 ± 15.3 0.28
Sex, F/M 8/36 11/45 0.07
Stage 1,2/Stage 3 28/16 52/4 <0.0001*
Hb, g/dL 12 ±1.3 13 ± 1.3 <0.001*
PDW, % 14.9 ± 2.2 14.4 ± 1.9 0.32
PCT, % 0.39 ± 0.08 0.26 ± 0.06 <0.0001*
WBC, μL 9400 ± 2264 7745 ± 1912 <0.0001*
ESR, mm/h 85 ± 20 57 ± 23 <0.0001*
CRP, mg/L 9.2 ±4.4 4.1 ±3.7 <0.0001*
*Significant value (p < 0.05).
PTB, Pulmonary tuberculosis; Hb, Hemoglobin; PDW, Platelet distribution
width; PCT,Plateletcrit; WBC, White blood cell; ESR,Eritrocyte sedimentation
rate; CRP, C-reactive protein.
Figure 1 ROC curve for using PLT levels in differential diagnosis of pulmonary tuberculosis and pneumonia. Comparison of groups at
the best cut-off point (335.000/μL).
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negative predictive value as 46.3% (Figure 3).
The best PCT cut-off value in differential diagnosis of
tuberculosis and pneumonia + healthy control was
defined as 0.26%. For this cut off value, sensitivity was
found as 68%, specificity as 67.9%, positive predictive
value as 73.1% and negative predictive value as 62.4%
(Figure 4).
Discussion
Reactive thrombocytosis developing in PTB has been
shown to be correlated with acute phase reactants andFigure 2 ROC curve for using PLT levels in differential diagnosis of pu
Comparison of groups at the best cut-off point (320.500/μL).severity of the disease [3,4,9]. In this study, we found
thrombocytosis in 44% of PTB patients. The increase of
the platelet counts in advanced stage PTB was correlated
both with the increase in CRP and ESR. Referring to the
indices of platelets, PCT was found higher in PTB than
in pneumonia and control groups, while PDW was
found increased only in PTB, not in healthy controls.
PCT was accepted as an indicator of circulating platelets
in a unit volume of blood [10]. Our results indicate that
the increase in PCT is more distinctive and significant
for tuberculosis than the other platelet indices. Tozko-
paran et al. found platelet count and all indices (PDW,lmonary tuberculosis and pneumonia + healthy control.
Figure 3 ROC curve for using PCT levels in differential diagnosis of pulmonary tuberculosis and pneumonia. Comparison of groups at
the best cut-off point (0.275%).
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and inactive tuberculosis. They demonstrated that these
values decrease to normal levels after the treatment.
They pointed out that the increase in platelet count and
indices might be used in addition to the other parameters
in order to evaluate the activation of tuberculosis [1].
In earlier studies, multiple microthrombi have been
found to occur around the tuberculosis cavity, and this
has been thought to be a defense mechanism prevent-
ing the dissemination of tuberculosis [11]. Similarly,
Khechinashvili et al. demonstrated with electron mi-
croscopy that the structure of the platelet changes inFigure 4 ROC curve for using PCT levels in differential diagnosis of p
Comparison of groups at the best cut-off point (0.26%).fibrocavernous tuberculosis and supposed that this struc-
tural change might be associated with the immunological
process of tuberculosis [11,12]. In our study, PLT, PCT,
WBC, CRP and ESR values were significantly higher both
in PTB and pneumonia groups than in healthy controls.
PLT and PCT values were higher, while CRP, ESR and
WBC values were lower in PTB than in the pneumonia
group. However, although the increase in PLT was corre-
lated with acute phase reactants (CRP, ESR) in PTB, in
pneumonia there was no correlation. These results sug-
gest that platelets might play a different role in the in-
flammatory response developing against PTB.ulmonary tuberculosis and pneumonia + healthy control.
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strated that hematological abnormalities are more com-
mon in severe tuberculosis. The most common of their
findings were anemia, leukocytosis, leukopenia and
thrombocytosis [5]. Again in a similar study from India,
full blood count, bone marrow (BM) aspiration and BM
biopsy were carried out in 32 patients with dissemi-
nated/miliary and 23 with pulmonary tuberculosis. The
most common findings were thrombocytopenia and se-
vere anemia in patients with disseminated/miliary and
thrombocytosis in those with pulmonary tuberculosis
[13]. Other studies also reported the most common find-
ings in patients with pulmonary tuberculosis as anemia,
leukocytosis, elevated ESR and thrombocytosis [4,14-17].
In our study, we found PLT, PCT, ESR and CRP values
higher and Hb value lower in the advanced stage PTB
compared to the other stages. Furthermore, the increase
in PLT was correlated with the increase in CRP and
ESR. Thus, we demonstrated the increase in platelet
count and inflammatory response to be higher in
advanced stage PTB, with a positive correlation between
them. In line with our study, there are in the literature
several investigations showing the acute phase response
to be greater in the severe tuberculosis [1,18,19].
Ünsal et al. found levels of IL6 and CRP higher in PTB
patients with thrombocytosis than in those with PTB
and a normal platelet count. They pointed out the in-
flammatory response to be greater in PTB patients with
thrombocytosis, and this is possibly associated with IL-6
[2]. Similarly,Baynes et al. showed that there is a signifi-
cant correlation between the degree of thrombocytosis
and that of inflammation (ESR and CRP values) in PTB
[20]. In an in vitro study, platelet activation was evalu-
ated according to the levels of platelet factor-4, and a
correlation of good degree was shown between the plate-
let activation and radiological extent of tuberculosis [9].
In our study we also found ESR, CRP, WBC and PCT
values to be higher, and Hb value lower, in PTB patients
with thrombocytosis than in those with a normal platelet
count. In addition, we encountered the disease with
radiological advanced stage more frequently in the tu-
berculosis patients with thrombocytosis.
Conclusions
Our study indicated that following different results com-
pared to other studies:
– WBC, ESR, CRP and PCT values were higher in the
tuberculosis patients with thrombocytosis compared
to those with a normal platelet count (p < 0.0001).
– PDW was higher in the tuberculosis group than in
healthy controls (p < 0.05), whereas there is no
correlation between pneumonia group and healthy
controls (p > 0.05).– PLT was correlated with CRP and ESR values in the
tuberculosis group, while it was not in the
pneumonia group.
– Only PLT and PCT were correlated with radiological
extent in the PTB group.
– No significant difference was found in levels of MPV
in patients with tuberculosis and pneumonia
compared to healthy controls.
In summary, it is known that thrombocytosis is caused
by chronic inflammation, and the extensive PTB disease
is the result of a diagnostic delay (PTB history of several
months). This study indicates that reactive thrombocyto-
sis and higher PCT and PDW levels develop frequently
in PTB and there is a strong correlation between throm-
bocytosis and acute phase reactants, that is the inflam-
matory response. In addition, tuberculosis with
radiological advanced stage is seen more frequently in
patients with thrombocytosis and higher PCT levels,
thus drawing attention to a possible role of platelets in
the immunopathogenesis of tuberculosis.
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